[go: up one dir, main page]

FR2834294B1 - Virus hxhv, materiel nucleique, materiel peptidique et utilisations - Google Patents

Virus hxhv, materiel nucleique, materiel peptidique et utilisations

Info

Publication number
FR2834294B1
FR2834294B1 FR0117048A FR0117048A FR2834294B1 FR 2834294 B1 FR2834294 B1 FR 2834294B1 FR 0117048 A FR0117048 A FR 0117048A FR 0117048 A FR0117048 A FR 0117048A FR 2834294 B1 FR2834294 B1 FR 2834294B1
Authority
FR
France
Prior art keywords
nucleic
peptide
hxhv virus
hxhv
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0117048A
Other languages
English (en)
Other versions
FR2834294A1 (fr
Inventor
Isabelle Chemin
Christian Trepo
Frederic Bedin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Biomerieux SA
Priority to FR0117048A priority Critical patent/FR2834294B1/fr
Priority to PCT/FR2002/004578 priority patent/WO2003055994A1/fr
Priority to EP02801182A priority patent/EP1458857A1/fr
Priority to US10/499,805 priority patent/US7479386B2/en
Priority to JP2003556514A priority patent/JP2005512594A/ja
Priority to AU2002364882A priority patent/AU2002364882A1/en
Publication of FR2834294A1 publication Critical patent/FR2834294A1/fr
Application granted granted Critical
Publication of FR2834294B1 publication Critical patent/FR2834294B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0117048A 2001-12-28 2001-12-28 Virus hxhv, materiel nucleique, materiel peptidique et utilisations Expired - Fee Related FR2834294B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0117048A FR2834294B1 (fr) 2001-12-28 2001-12-28 Virus hxhv, materiel nucleique, materiel peptidique et utilisations
PCT/FR2002/004578 WO2003055994A1 (fr) 2001-12-28 2002-12-27 Virus hxhv, matériel nucléique, matériel peptidique et utilisations
EP02801182A EP1458857A1 (fr) 2001-12-28 2002-12-27 Virus hxhv, mat riel nucl ique, mat riel peptidique et utilisations
US10/499,805 US7479386B2 (en) 2001-12-28 2002-12-27 HXHV virus, nucleic material, peptide material and uses
JP2003556514A JP2005512594A (ja) 2001-12-28 2002-12-27 Ｈｘｈｖウイルス、核物質、ペプチド物質および用途
AU2002364882A AU2002364882A1 (en) 2001-12-28 2002-12-27 Hxhv virus, nucleic material, peptide material and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0117048A FR2834294B1 (fr) 2001-12-28 2001-12-28 Virus hxhv, materiel nucleique, materiel peptidique et utilisations

Publications (2)

Publication Number Publication Date
FR2834294A1 FR2834294A1 (fr) 2003-07-04
FR2834294B1 true FR2834294B1 (fr) 2004-02-06

Family

ID=8871084

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0117048A Expired - Fee Related FR2834294B1 (fr) 2001-12-28 2001-12-28 Virus hxhv, materiel nucleique, materiel peptidique et utilisations

Country Status (6)

Country Link
US (1) US7479386B2 (fr)
EP (1) EP1458857A1 (fr)
JP (1) JP2005512594A (fr)
AU (1) AU2002364882A1 (fr)
FR (1) FR2834294B1 (fr)
WO (1) WO2003055994A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857023B1 (fr) * 2003-07-04 2007-10-19 Biomerieux Sa Sequences nucleiques et proteiques du virus hxhv et utilisations
DE102005028523A1 (de) * 2005-05-19 2006-11-23 Plus Orthopedics Ag Gelenkpfanne für eine Hüftgelenkendoprothese, Prothese mit einer derartigen Gelenkpfanne und Protheseset
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
DE102012011660A1 (de) * 2012-06-13 2013-12-19 Daimler Ag Wischblatt, Wischarm und Verbindungsanordnung für eine Scheibenwischanlage eines Fahrzeugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics

Also Published As

Publication number Publication date
US7479386B2 (en) 2009-01-20
EP1458857A1 (fr) 2004-09-22
WO2003055994A9 (fr) 2004-04-22
JP2005512594A (ja) 2005-05-12
FR2834294A1 (fr) 2003-07-04
AU2002364882A1 (en) 2003-07-15
US20050037336A1 (en) 2005-02-17
WO2003055994A1 (fr) 2003-07-10

Similar Documents

Publication Publication Date Title
DE60329983D1 (de) Wachsestersynthase-dna-sequenz, protein und verwendungen davon
NL1019917A1 (nl) HoogefficiÙnte fluorescerende stof.
DK1278763T3 (da) 3-Nitrogen-6,7-dioxygensteroider og anvendelser relateret dertil
EP1419245A4 (fr) Virus adeno-associes pseudotypes et utilisations de ces derniers
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DE60121555D1 (de) Fixier- und Dichtmattenmaterial
MA26348A1 (fr) 2-thio-3,5-dicyano-4-phenyl-6-aminopyridine substituees et leur utilisation
DE60215046D1 (de) Vernebler und anwendungsverfahren
DE60012213D1 (de) Fünfgliedrige n-heterocyclen mit hypoglykämischer und hypolipidemischer wirkung
DE60139127D1 (de) Von hepatitis c virus
NO20026110L (no) Konstruksjonsmateriale
DE60236099D1 (de) Druckverfahren, druckerzeugnisse und drucksteuerung
ID26599A (id) Turunan triazola dan imidazola
NO20030239L (no) Modifisert virus
ID26611A (id) Turunan-turunan pirol tersubstitusi heteroaril, pembuatannya dan kegunaan-kegunaan terapetiknya
NO20013102L (no) Gener, proteiner og deres anvendelse
DE60223540D1 (de) Mundschutz und mundschutzfolie
FR2834294B1 (fr) Virus hxhv, materiel nucleique, materiel peptidique et utilisations
ATE312062T1 (de) Baumaterial
DE69905620D1 (de) Hitzebeständiges, flammhemmendes material und varianten
DE60223474D1 (de) Dichtungsmaterial
NO20013101D0 (no) Ytre overflateproteiner, deres gener og deres anvendelse
AU2003246485A8 (en) Interactions of the epstein-barr virus protein ebna1, and uses thereof
EP1433849A4 (fr) Nouveau polypeptide, adn associe et utilisation de ce polypeptide
EP1395276A4 (fr) Peptides structurellement modifies et leurs utilisations

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070831